Marcaine 1:200.000 EPI, 50/Pkg

Marcaine 1:200,000 EPI Injection – Anesthetics Category
Marcaine 1:200,000 EPI injection is a high-quality anesthetic solution designed for effective pain management in medical procedures. This formulation combines bupivacaine hydrochloride with epinephrine 1:200,000 to provide long-lasting local anesthesia with controlled vasoconstriction.

• Bupivacaine hydrochloride concentration: 0.5%
• Epinephrine concentration: 1:200,000 (as bitartrate)
• Quantity: 50 injections per box
• Preparation: Sterile, USP grade
• Application: Local anesthesia with vasoconstrictor effects

Compared to many standard anesthetic solutions, Marcaine 1:200,000 EPI offers enhanced duration of action and reduced systemic absorption due to the inclusion of epinephrine, which constricts blood vessels at the injection site. This combination makes it a preferred choice over traditional formulations lacking vasoconstrictors, resulting in improved pain control and decreased bleeding during surgical interventions. Previous models of Marcaine without epinephrine demonstrated effective anesthesia but with shorter duration and slightly higher rates of systemic side effects.

Key Technical Advantages:
Technology and Performance
The incorporation of epinephrine at a concentration of 1:200,000 optimizes the anesthetic effect by prolonging the activity of bupivacaine, reducing local blood flow, and minimizing systemic uptake. The 0.5% bupivacaine concentration ensures a potent and reliable nerve blockade, making it suitable for various clinical applications that require sustained anesthesia. Packaging 50 doses per box supports efficient inventory management in medical facilities, combining convenience with consistent dosage quality. This anesthetic solution complies with USP standards, ensuring sterility and safety for patients.

Overall, Marcaine 1:200,000 EPI injection stands out in the anesthetics category due to its superior formulation that balances potency, safety, and duration for enhanced patient outcomes during minor and major procedures.